Top Stories

GlaxoSmithKline launches Cervarix in UK, pricing similar to Gardasil

October 02, 2007

GlaxoSmithKline launched its cervical cancer vaccine Cervarix in the UK on Tuesday, pricing it at about the same level as rival treatment, Merck’s Gardasil.
 

FDA slammed on clinical trials oversight

September 28, 2007

The FDA is failing to adequately police clinical trials, according to a report by the inspector general of the Department of Health and Human Services.
 

Bristol-Myers Squibb in integrity agreement as part of settlement

September 28, 2007

Bristol-Myers Squibb (BMS) has entered into a corporate integrity agreement (CIA) with the Office of Inspector General of the Department of Health and Human Services as part of a civil settlement to resolve allegations that the company inflated its drug prices and was involved in kickbacks to doctors.
 

In Other News

InVentiv launches compliance/adherence business

October 02, 2007

InVentiv Health is launching a business aimed at improving patient compliance and adherence.
 

Galvus garners EU approval

October 01, 2007

Novartis' Type 2 diabetes drug Galvus has won marketing approval in Europe.
 

Poussot to take over as Wyeth CEO

September 28, 2007

Wyeth will promote its No. 2 executive, Bernard Poussot, to CEO effective Jan.1 under a planned succession, the drugmaker said.
 

MM&M Awards tickets now on sale

August 28, 2007

Tickets for the MM&M Awards 2007 presentation dinner are now on sale.
 

Product news

October 02, 2007

Japanese pharmaceutical company Daiichi Sankyo said the FDA has approved Azor, a drug to treat high blood pressure.
 

People news

October 02, 2007

AstraZeneca tapped Simon Lowth, former finance chief at energy company Scottish Power, as its new chief financial officer, effective Nov. 5.
 




Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.